Low-dose amphotericin B lipid complex vs. conventional amphotericin B for empirical antifungal therapy of neutropenic fever in patients with hematologic malignancies--a randomized, controlled trial. [electronic resource]
Producer: 20040517Description: 342-7 p. digitalISSN:- 0902-4441
- Adult
- Amphotericin B -- administration & dosage
- Antifungal Agents -- administration & dosage
- Antineoplastic Combined Chemotherapy Protocols -- adverse effects
- Chemical and Drug Induced Liver Injury -- etiology
- Combined Modality Therapy
- Drug Combinations
- Female
- Fever of Unknown Origin -- etiology
- Hematologic Neoplasms -- complications
- Humans
- Hypokalemia -- chemically induced
- Immunocompromised Host
- Incidence
- Kidney Diseases -- chemically induced
- Male
- Middle Aged
- Mycoses -- drug therapy
- Neutropenia -- chemically induced
- Peripheral Blood Stem Cell Transplantation -- adverse effects
- Phosphatidylcholines -- administration & dosage
- Phosphatidylglycerols -- administration & dosage
- Treatment Outcome
No physical items for this record
Publication Type: Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.